Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

A new review of depression treatments suggests that the scientific evidence for many common strategies used when a first ...

Please provide your email address to receive an email when new articles are posted on . Anxiety and depression treatment should follow a stepped-care approach based on the severity of symptoms.

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...

ANN ARBOR, Mich. (CBS DETROIT) - Doctors across the country are turning to widely-known anesthetic and party drug ketamine to treat patients with severe depression. Ketamine was approved as a general ...

Published in the Oct. 30, 2025 edition of Frontiers in Pharmacology, the new post-hoc analysis showed that patients who took the GeneSight test were at any given time during the 24-week study period ...